Search for: "Brian G. Lee" Results 1 - 20 of 122
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
20 Feb 2024, 7:09 pm by Mary Anne Peck
Lee , the senior vice president of legal and public affairs at the Center for Individual Freedom , a conservative, non-profit advocacy organization. [read post]
6 Jan 2024, 6:00 am by Meghan Conroy
Professor Lee Bebout of Arizona State University submitted a statement titled, “Weaponizing Victimhood in U.S. [read post]
19 Nov 2023, 11:28 am by admin
Clapp,*James Dahlgren,*Devra Lee Davis,Malin Roy Dollinger,*Brian G. [read post]
14 Aug 2023, 5:36 am by Guest Author
This is Volume IV of the major questions doctrine (“MQD”) reading list. [read post]
7 Jul 2023, 1:03 pm by Ryan Goodman
Wood (Assistant Professor, The Ohio State University)“President Trump’s Rhetoric Undermined Confidence in Elections Among His Supporters” Expert Statement  Patrick G. [read post]
30 Jun 2023, 6:30 am
Carper, Skadden, Arps, Slate, Meagher & Flom LLP, on Sunday, June 25, 2023 Tags: Controlling shareholders, Corporate fraud, Delaware articles, Delaware cases, Delaware Court of Chancery, Delaware law, standard of review Dynamic CEO-Board Cultural Proximity Posted by Philip G. [read post]
30 Jun 2023, 6:30 am
Carper, Skadden, Arps, Slate, Meagher & Flom LLP, on Sunday, June 25, 2023 Tags: Controlling shareholders, Corporate fraud, Delaware articles, Delaware cases, Delaware Court of Chancery, Delaware law, standard of review Dynamic CEO-Board Cultural Proximity Posted by Philip G. [read post]
23 Dec 2022, 6:30 am
Evidence from Plant-Level Data Posted by John Bai (Northeastern University), Anya Mkrtchyan (UMass Amherst), on Tuesday, December 20, 2022 Tags: Board of Directors, CEO turnovers, CEOs, Outside CEOs, SEC, TFP The Activism Vulnerability Report – Q3 2022 Posted by Jason Frankl and Brian G. [read post]
23 Dec 2022, 6:30 am
Evidence from Plant-Level Data Posted by John Bai (Northeastern University), Anya Mkrtchyan (UMass Amherst), on Tuesday, December 20, 2022 Tags: Board of Directors, CEO turnovers, CEOs, Outside CEOs, SEC, TFP The Activism Vulnerability Report – Q3 2022 Posted by Jason Frankl and Brian G. [read post]
7 Oct 2022, 6:30 am
Fisch (University of Pennsylvania Carey School of Law) and Xian Gu (Durham University Business School) , on Wednesday, October 5, 2022 Tags: Comment letters, compliance, Disclosure, Foreign firms, SEC, SEC enforcement, Securities litigation How the SEC’s Executive Compensation Disclosure Rule Could Impact the 2023 Proxy Season Posted by Sydney Carlock, Martha Carter, and Sean Quinn, Teneo, on Thursday, October 6, 2022 Tags: Disclosure, Executive Compensation, Proxy voting, SEC,… [read post]